State Street’s Endovia Health Sciences, Inc. EDVA Stock Holding History

State Street’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-537	Closed	-$13.8K	–	4306
2024 Q4	$13.8K	Hold	537	–	–	﹤0.01%	4261
2024 Q3	$21.6K	Hold	537	–	–	﹤0.01%	4220
2024 Q2	$19.8K	Hold	537	–	–	﹤0.01%	4277
2024 Q1	$39.5K	Hold	537	–	–	﹤0.01%	4199
2023 Q4	$47.5K	Hold	537	–	–	﹤0.01%	4206
2023 Q3	$50.7K	Buy	537 +99	+23%	+$12.8K	﹤0.01%	4287
2023 Q2	$78.4K	Hold	438	–	–	﹤0.01%	4294
2023 Q1	$115K	Hold	438	–	–	﹤0.01%	4280
2022 Q4	$67.3K	Hold	438	–	–	﹤0.01%	4483
2022 Q3	$96K	Hold	438	–	–	﹤0.01%	4478
2022 Q2	$209K	Hold	438	–	–	﹤0.01%	4176
2022 Q1	$199K	Buy	438 +227	+108%	+$116K	﹤0.01%	4384
2021 Q4	$39K	Buy	+211	New	+$57K	﹤0.01%	4735

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street's EDVA Position: Q1 2025 in Review

State Street sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 537 shares — an estimated $13.8K sold.

State Street first reported a position in EDVA in Q4 2021 and held it in 13 quarters. The position peaked at $209K in Q2 2022. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

State Street reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
State Street sold 537 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $13.8K.
State Street first reported a position in Endovia Health Sciences, Inc. in Q4 2021 and held it in 13 quarters.
State Street's Endovia Health Sciences, Inc. position peaked at $209K in Q2 2022.
11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.